Wall Street Breakfast Podcast: AI: 11% Of Healthcare Budgets

The budget for artificial intelligence and machine learning in the healthcare sector is expected to reach 10.5% in 2024, up from 5.5% in 2022, and could have transformational effects on the industry beyond drug discovery, according to Morgan Stanley. Private equity firm Thoma Bravo is also in talks to acquire NextGen Healthcare, while Nestle-partnered weight loss capsules have succeeded in a pivotal trial, boosting shares of Epitomee Medical.

seekingalpha.com

Relevant topic timeline:

8/21/2023

3 Reasons Why The Biopharma M&A Market Is Ready For Takeoff

M&A activity in the healthcare sector has been slow in 2023, but experts predict an influx of biopharma M&A deals in the second half of the year due to a looming patent cliff, low valuations, and a weak IPO market. Several large pharmaceutical companies are seeking late-stage assets to offset revenue decline from expiring patents. The low valuations of biotech companies make them attractive to buyers, and the slow IPO market further drives M&A activity. However, antitrust scrutiny from federal regulators could pose a potential challenge.

8/29/2023

The company landscape for artificial intelligence in large-molecule drug discovery

Artificial intelligence (AI) techniques, particularly machine learning, are increasingly being used in drug research and development (R&D), with applications expanding beyond small molecules to include large-molecule modalities such as antibodies, gene therapies, and RNA-based therapies. These therapies, which make up a significant portion of the biopharma industry's current and future commercial potential, are expected to represent approximately 50% of the oncology market by revenue in 2030, with the majority coming from antibodies.

9/4/2023

Despite a slower Q2, Needham sees medtech market growing 7% in 2023 (NYSE:BSX)

Despite slowed growth in Q2, the medtech sector is projected to grow by 7% in 2023, with double-digit growth in certain cardiology categories, and AtriCure, Alcon, Alphatec, Glaukos, and SI-BONE being the top-ranked companies, according to Needham.

9/6/2023

Thoma Bravo to take NextGen Healthcare private for $1.6 billion

Private-equity firm Thoma Bravo has agreed to acquire healthcare software provider NextGen Healthcare for $1.61 billion, as private equity firms continue to invest in the resilient healthcare industry.

9/11/2023

Pharma Market Boom Coming: TBRC Reports Reveal $3 Trillion Industry by 2030 Driven by Disease, Healthcare Advances

The pharmaceutical market is expected to grow significantly by 2030, reaching $3,206 billion, driven by advances in healthcare technologies, increasing healthcare expenditures, and the rise of chronic diseases. The Business Research Company offers comprehensive reports to assist pharmaceutical companies with informed decision-making and staying competitive in this dynamic sector.

9/21/2023

Sanofi Bets on AI to Boost Drug Development and Ease Medicare Price Pressure

Sanofi CEO Paul Hudson believes that AI will play a significant role in the pharmaceutical industry by expediting the drug development timeline, which has become even more crucial due to pressure from the Inflation Reduction Act. Sanofi has made several investments in AI-focused pharmaceutical companies and aims to be the first at-scale AI pharmaceutical company.

Topics

Posted 9/5/2023, 11:00:57 AM